Tech Company Financing Transactions
3-V Biosciences Funding Round
3-V Biosciences closed a $5.4 million funding round on 7/6/2016. Investors included private investors.
Transaction Overview
Company Name
Announced On
7/6/2016
Transaction Type
Venture Equity
Amount
$5,437,612
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 7 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3715 Haven Ave. 220
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
3-V Biosciences is a biopharmaceutical company developing therapeutics for the treatment of infectious diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
George Kemble
Chief Medical Officer
William McCulloch
Vice President
Douglas Buckley
Browse more venture capital transactions:
Prev: 7/6/2016: Twistlock venture capital transaction
Next: 7/6/2016: MiniLuxe venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs